UGDH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.595000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.396200E-01
Normal-vs-Stage2
2.605400E-01
Normal-vs-Stage3
5.100600E-01
Normal-vs-Stage4
6.283700E-02
Stage1-vs-Stage2
5.255400E-01
Stage1-vs-Stage3
7.669600E-01
Stage1-vs-Stage4
1.142200E-01
Stage2-vs-Stage3
4.783600E-01
Stage2-vs-Stage4
6.257800E-01
Stage3-vs-Stage4
8.410300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.667800E-01
Normal-vs-AfricanAmerican
2.789200E-01
Normal-vs-Asian
3.768200E-01
Caucasian-vs-AfricanAmerican
6.322600E-01
Caucasian-vs-Asian
8.829900E-02
AfricanAmerican-vs-Asian
3.262200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.880600E-01
Normal-vs-Female
2.347800E-01
Male-vs-Female
7.312200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.755200E-01
Normal-vs-Age(41-60Yrs)
1.139380E-01
Normal-vs-Age(61-80Yrs)
3.491200E-01
Normal-vs-Age(81-100Yrs)
3.981400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.212800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.979400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.479200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.942500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.003800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.989800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.829800E-01
Normal-vs-Daily Drinker
5.205800E-01
Normal-vs-Weekly Drinker
2.105000E-01
Normal-vs-Occasional Drinker
1.027610E-01
Normal-vs-Social Drinker
3.294600E-01
Non Drinker-vs-Daily Drinker
4.517800E-01
Non Drinker-vs-Weekly Drinker
4.007000E-01
Non Drinker-vs-Occasional Drinker
5.325600E-02
Non Drinker-vs-Social Drinker
8.710400E-01
Daily Drinker-vs-Weekly Drinker
1.283420E-01
Daily Drinker-vs-Occasional Drinker
1.063880E-02
Daily Drinker-vs-Social Drinker
3.947000E-01
Weekly Drinker-vs-Occasional Drinker
3.664400E-01
Weekly Drinker-vs-Social Drinker
5.319200E-01
Occasional Drinker-vs-Social Drinker
1.225970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.178200E-01
Normal-vs-Grade 2
9.932400E-01
Normal-vs-Grade 3
8.167600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.222600E-01
Grade 1-vs-Grade 3
1.383000E-01
Grade 1-vs-Grade 4
8.178200E-01
Grade 2-vs-Grade 3
3.058800E-01
Grade 2-vs-Grade 4
9.932400E-01
Grade 3-vs-Grade 4
8.167600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.578400E-01
Normal-vs-NonDiabetic
2.955400E-01
Diabetic-vs-NonDiabetic
8.637200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.150400E-01
Normal-vs-NoPancreatitis
2.683200E-01
Pancreatitis-vs-NoPancreatitis
4.771400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.088400E-01
Normal-vs-N1
2.430800E-01
N0-vs-N1
4.620000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.117400E-01
Normal-vs-TP53-NonMutant
6.099800E-01
TP53-Mutant-vs-TP53-NonMutant
6.587900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
